Form 4 for ZNTL Zentalis Pharmaceuticals, Inc.
Accepted 2022-10-03 00:00:00 ET · period of report 2022-10-03 · accession 0001725160-22-000179 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-10-03 | 2022-10-03 | ZNTL | Bunker Kevin D. | CSO | A - Grant | $0.00 | +50.0K | 814.1K | +7% | $0 |
| D | 2022-10-03 | 2022-10-03 | ZNTL | Bunker Kevin D. | CSO | A - Grant | $0.00 | +50.0K | 50.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-03 | A | A | 50,000 | $0.00 | 814,110 | D | — | — | (F1) Represents restricted stock units ("RSUs") granted by the Issuer under the Zentalis Pharmaceuticals, Inc. 2020 Incentive Award Plan, as amended (the "2020 Plan"). The RSUs will vest over two years: 1/3 of the RSUs will vest on the first anniversary of the date of grant, and the remaining 2/3 of the RSUs will vest on the second anniversary of the date of grant. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-10-03 | A | A | 50,000 | $0.00 | 50,000 | D | $22.21 · — to 2032-10-02 | 50,000 Common Stock | (F3) The options were granted by the Issuer under the 2020 Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer. |